These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
69 related articles for article (PubMed ID: 20368229)
1. Pioglitazone improves superoxide dismutase mediated vascular reactivity in the obese Zucker rat. Dorafshar AH; Moodley K; Khoe M; Lyon C; Bryer-Ash M Diab Vasc Dis Res; 2010 Jan; 7(1):20-7. PubMed ID: 20368229 [TBL] [Abstract][Full Text] [Related]
2. Effect of pioglitazone on L-NAME induced hypertension in diabetic rats. Majithiya JB; Parmar AN; Trivedi CJ; Balaraman R Vascul Pharmacol; 2005 Oct; 43(4):260-6. PubMed ID: 16168716 [TBL] [Abstract][Full Text] [Related]
3. Telmisartan provides protection against development of impaired vasodilation independently of metabolic effects in SHRSP.Z-Lepr(fa)/IzmDmcr rats with metabolic syndrome. Kagota S; Tada Y; Nejime N; Nakamura K; Kunitomo M; Shinozuka K Can J Physiol Pharmacol; 2011 May; 89(5):355-64. PubMed ID: 21619437 [TBL] [Abstract][Full Text] [Related]
4. Improved metabolic status and insulin sensitivity in obese fatty (fa/fa) Zucker rats and Zucker Diabetic Fatty (ZDF) rats treated with the thiazolidinedione, MCC-555. Upton R; Widdowson PS; Ishii S; Tanaka H; Williams G Br J Pharmacol; 1998 Dec; 125(8):1708-14. PubMed ID: 9886762 [TBL] [Abstract][Full Text] [Related]
5. Fenofibrate and pioglitazone do not ameliorate the altered vascular reactivity in aorta of isoproterenol-treated rats. Fukuda LE; Davel AP; Verissimo-Filho S; Lopes LR; Cachofeiro V; Lahera V; Rossoni LV J Cardiovasc Pharmacol; 2008 Nov; 52(5):413-21. PubMed ID: 19033820 [TBL] [Abstract][Full Text] [Related]
6. Pioglitazone enhances the antihypertensive and renoprotective effects of candesartan in Zucker obese rats fed a high-protein diet. Namikoshi T; Tomita N; Satoh M; Haruna Y; Kobayashi S; Komai N; Sasaki T; Kashihara N Hypertens Res; 2008 Apr; 31(4):745-55. PubMed ID: 18633187 [TBL] [Abstract][Full Text] [Related]
13. The thiazolidinedione rosiglitazone (BRL-49653) lowers blood pressure and protects against impairment of endothelial function in Zucker fatty rats. Walker AB; Chattington PD; Buckingham RE; Williams G Diabetes; 1999 Jul; 48(7):1448-53. PubMed ID: 10389852 [TBL] [Abstract][Full Text] [Related]
14. Effects of pioglitazone on glucose and lipid metabolism in normal and insulin resistant animals. Ikeda H; Taketomi S; Sugiyama Y; Shimura Y; Sohda T; Meguro K; Fujita T Arzneimittelforschung; 1990 Feb; 40(2 Pt 1):156-62. PubMed ID: 2334455 [TBL] [Abstract][Full Text] [Related]
15. Antihypertensive effect of ragaglitazar: a novel PPARalpha and gamma dual activator. Mamnoor PK; Hegde P; Datla SR; Damarla RK; Rajagopalan R; Chakrabarti R Pharmacol Res; 2006 Aug; 54(2):129-35. PubMed ID: 16651004 [TBL] [Abstract][Full Text] [Related]
16. Arterial blood pressure and aortic responses in obese, age-grouped Zucker rats. Sanchez D; Miguel M; Aleixandre A Methods Find Exp Clin Pharmacol; 2010; 32(6):421-6. PubMed ID: 20852751 [TBL] [Abstract][Full Text] [Related]
17. Estrogen has opposing effects on vascular reactivity in obese, insulin-resistant male Zucker rats. Brooks-Asplund EM; Shoukas AA; Kim SY; Burke SA; Berkowitz DE J Appl Physiol (1985); 2002 May; 92(5):2035-44. PubMed ID: 11960955 [TBL] [Abstract][Full Text] [Related]
18. Effects of pioglitazone and rosiglitazone on aortic vascular function in rat genetic hypertension. Llorens S; Mendizabal Y; Nava E Eur J Pharmacol; 2007 Dec; 575(1-3):105-12. PubMed ID: 17803988 [TBL] [Abstract][Full Text] [Related]
19. Mechanisms underlying the chronic pioglitazone treatment-induced improvement in the impaired endothelium-dependent relaxation seen in aortas from diabetic rats. Matsumoto T; Noguchi E; Kobayashi T; Kamata K Free Radic Biol Med; 2007 Apr; 42(7):993-1007. PubMed ID: 17349927 [TBL] [Abstract][Full Text] [Related]
20. Pioglitazone increases gallbladder volume in insulin-resistant obese mice. Al-Azzawi HH; Mathur A; Lu D; Swartz-Basile DA; Nakeeb A; Pitt HA J Surg Res; 2006 Dec; 136(2):192-7. PubMed ID: 17045610 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]